Professional Documents
Culture Documents
www.pharmacydaily.com.au
Todays issue of PD
Pharmacy Daily today has
Pharmaxis $14m from BI Trial recruiting adults
Curtin University has launched
Sydney-based research the 10 million we expect for the a new clinical trial to investigate a
two pages of news, our Winter
pharmaceutical company second indication would bring strategy for treating hypertension
Spotlight feature on page 3
Pharmaxis has announced total expected milestones received and seeks to recruit more than 100
and a full page from Pharmacy
that Boehringer Ingelheim (BI) for starting phase 2 trials in two West Australian adults (older than
4 Less. 18 years) to volunteer to take part
is injecting more funds into the diseases to approximately A$42
development of Pharmaxis drug million in this calendar year. through The Healthy Living Clinic at
Know Pneumonia Day development asset PXS-4728A. This is an important signal the University.
Three-in-four Australian In addition to a phase 2 trial in about Boehringer confidence in The QUARTET clinical trial, funded
adults do not consider life- Non-Alcoholic SteatoHepatitis the potential of PXS-4728A to help by a grant from the National Health
threatening consequences as (NASH) that is scheduled to start patients. and Medical Research Council, will
sufficient motivation to vaccinate mid-year, BI has confirmed that a Further developments in assess whether a new treatment,
against pneumococcal pneumonia, phase 2 trial for a second indication the treatments of fibrosis and ultra-low-dose quadruple therapy
although 63% have at least one risk will also commence during 2017. inflammation are planned with (LDQT), will lower blood pressure
factor for contracting the often fatal As a result, Pharmaxis will receive the injection of these additional more effectively than standard dose
infection, says Lung Foundation its anticipated milestone payment funds so that the company can monotherapy - to find out more,
Australia. of 18 million for the start of the build capabilities to translate and call Curtin on (08) 9266 5860.
New research released today NASH trial but in addition, a further commercialise early stage research
by the Foundation reveals that
Australian children have a 93%
10 million (A$14 million) for the
second indication.
assets into products highly valued
by large pharma companies seeking
Thunderstorm asthma
pneumococcal vaccine uptake, Pharmaxis ceo Gary Phillips said, partnerships, he added. Asthma Australia
but there is a significant gap PXS-4728A is an anti-inflammatory BIs responsibilities under the is urging anyone
between pneumococcal pneumonia drug with excellent preclinical data agreement include all development, concerned about
vaccination rates (46%) and the in several disease models. regulatory, manufacturing and thunderstorm asthma,
much higher flu vaccination rates We are delighted to see commercialisation activities around following the somewhat
(69%) reported among equally Boehringer looking to exploit that PXS-4728A, Phillips said. alarming 60
vulnerable seniors aged 65+ years. potential and commence clinical Minutes
Visit knowpneumonia.org for development in a fresh indication in story on
more research details. the second half of this year.
New medicine labels the Victorian storm event
The structure of the deal with The Therapeutic Goods earlier this year, to consult their GP,
Boehringer anticipated its potential Administration (TGA) has pharmacist or call 1800 ASTHMA
Osteoporosis course in more than one disease and announced that labels on (278 462) for information and
medicines will need to identify any support.
Guild Learning and Development
possible allergens in addition to the The organisation advised people
has partnered with Sanofi-Aventis
with asthma to be vigilant going
Australia to develop a new Bexsero supply presently mandatory peanuts and
into the spring season if pollen is a
online course titled Vitamin D gluten references.
GSK has announced that in spite trigger, check with their GP about
supplementation in bone health. The additional substances include
of significant increases in supply of their Asthma Action Plan, keep up
Designed specifically for crustacea, fish, eggs, soya, milk and
Bexsero (meningococcal B) vaccine regular preventer medication and
pharmacists, the study opportunity tree nuts, although they may not
this year, it still isnt meeting take reliever medication at the first
will enable participants to describe appear for a few years with drug
demand and it is working hard to sign of breathlessness.
the process of bone metabolism, companies being given a grace
bring more doses into the country. The asthma support group also
including the role of vitamin D, period of four years to implement
The company is bringing an reminded patients to contact
as well as assisting pharmacists the requirements.
additional 200,000 doses of emergency services if first aid is not
in identifying patients who may For a full list of currently required
Bexsero into Australia and they will successful.
benefit from 7000IU once per label statements, visit tga.gov.au.
be available from pharmacies and
week vitamin D supplementation, GP surgeries from the start of Jun.
including important counselling We understand it has been
points and advice for patients.
With about half of all
distressing for parents who want
to protect their children against
Repairs
osteoporosis patients not realising
they have the disease until they
meningococcal B but havent been
able to access the vaccine, a GSK
damaged
suffer from a low-impact fracture, spokesperson said.
osteoporosis is a chronic and
frequently asymptomatic condition.
We hope these additional doses
will go along way to meet the
hands.
Being asymptomatic, compliance current demand.
is also often problematic in long Families can expect to pay in
term treatment, the Guild says. the range of $120-140 per dose
Contact the Guild Learning and of Bexsero depending on which
Development on 03 9810 9930 or pharmacy they visit.
learninganddevelopment@guild.org.au More info from GSK medical
for more information. information on 1800 033 109.
Pharmacy Daily Tuesday 16th May 2017 t 1300 799 220 w www.pharmacydaily.com.au page 1
OPTIMISE CARE TO THE
ELDERLY WITH THE AMH
AGED CARE COMPANION
A trusted, practical reference that contains
the latest evidence-based information and is
useful when conducting medication reviews and
other activities aimed at improving patient
outcomes. Available in hard copy or online.
Pharmacy Daily is Australias favourite pharmacy industry publication. Publisher/Editor in chief: Bruce Piper Editorial: info@pharmacydaily.com.au
Sign up free at www.pharmacydaily.com.au. Managing Editor: Jon Murrie
Postal address: PO Box 1010, Epping, NSW 1710 Australia Reporter: Mal Smith
Street address: Level 2, Suite 1 64 Talavera Rd, Macquarie Park NSW 2113 Australia Contributors: Matt Bell, Rebecca Le Bas, Jasmine ODonoghue
Advertising and Marketing: Sean Harrigan and Melanie Tchakmadjian advertising@pharmacydaily.com.au
P: 1300 799 220 (+61 2 8007 6760) F: 1300 799 221 (+61 2 8007 6769)
Business Manager: Jenny Piper accounts@pharmacydaily.com.au
Part of the Business Publishing Group.
business events news
Pharmacy Daily is a publication of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain written permission to reproduce any material. While every care has been taken in the preparation of
the newsletter no liability can be accepted for errors or omissions. Information is published in good faith to stimulate independent investigation of the matters canvassed. Responsibility for editorial comment is taken by Bruce Piper.
Pharmacy Daily Tuesday 16th May 2017 t 1300 799 220 w www.pharmacydaily.com.au page 2
Pharmacy Dailys Winter spotlight is your guide to all the essentials - from products to assist with coughs
and colds through to keeping you hydrated and vitamin boosted - ready for this years Winter season. To
feature here email advertising@pharmacydaily.com.au.
Dont let coughs have their say1 Preservative-Free Flo Rapid Relief
Prospan 200ml, Prospan Menthol 200ml and Prospan $12.95 RRP
Have you tried a PRESERVATIVE-FREE decongestant nasal spray
for Children 200ml, $20.95 RRP yet? Flo Rapid Relief helps clear a blocked or runny nose due to
Prospan for Children is Australias number one selling childrens colds, hay fever, allergies and sinus congestion. It starts working
cough medicine2. It contains an exclusive ivy leaf extract EA in minutes and lasts up to 10 hours.
575, which is the specific extract that has been shown in clinical
trials to provide chesty cough relief. Available in a great cherry After unblocking the nose, consider an irrigation kit or saline
taste, Prospan is suitable for anyone over 2. Its also available spray such as Flo Sinus Care or Flo Saline Plus to wash away
in a great tasting, fresh menthol flavour and is suitable for excess mucus, pollens and irritants. For those with allergies, a
anyone over 6. preservative-free decongestant spray may be helpful to clear the
Stockist inquiries: 1800 334 224 nose before using a medicated allergy nasal spray.
Always read the label. Use as directed. Consult your healthcare practitioner if symptoms
Website: www.flordis.com.au persist. Visit website for clinical data.
References: 1. Due to a cold. 2. MAT unit and dollar sales, 16/04/17, Pharmacy, Aztec Stockists: ENT Technologies 1300 857 912
sales data. Website: www.flo.com.au
Temporary relief
for Rheumatism
Joint Pain and
www.painstrikeoil.com.au
Muscle Pain.
45 091 PDE 34
5105
E3
PD
For Sales Enquiries Contact J&T World Trade Pty Ltd Tel: 02 9707 1919 Fax: 02 9707 2351 info@painstrikeoil.com.au
Maters baby care range - perfect for winter skin Pain Strike Oil
Baby Wash $13.99 RRP Baby Moisturiser $14.99 RRP From $11.99 RRP
As winter settles in our skin starts to feel the effects of indoor In the bid for a healthier, pain free lifestyle without the
heating and a lack of moisture. Babies skin, with distinct additions of nasty chemicals, PAIN STRIKE OIL has developed
differences to adult skin regarding epidermal barrier function, a range of natural herbal medicines to aid and assist in the
sensitivity and pH level, is also particularly prone at this time of maintenance of general wellbeing and overcoming joint and
year with the potential for infection, dermatitis and dryness. muscle pain.
Mater Mothers Hospitals Mater Baby Wash and Mater Baby Australian owned and operated, PAIN STRIKE OIL contains
Moisturiser are specifically developed for sensitive newborn four active ingredients; Cajuput Oil, Camphor Oil White, Clove
skin, pH balanced and dermatologically tested. Bud Oil and Wintergreen Oil.
Orders can be placed through Symbion or directly from J&T
Gift with Purchase consumer promo available in May contact World Trade Pty Ltd Phone 02 9707 1919 Fax: 02 9707 2153
Mater 1300 162 837 or products@mater.org.au Website: www.painstrikeoil.com.au
AUSTRALIAS
FASTEST
GROWING
PHARMACY
CHAIN IS NOW
IN TASMANIA!
JOIN A
PROVEN
PHARMACY
FRANCHISE
MODEL
If you want an effective National Brand
to equip you with the right strategies
& tools to excel, give us a call today.
Join Australias Fastest Growing
Pharmacy Franchise